JP Morgan Call 230 PGR 20.06.2025/ DE000JT0DKF9 /
15/08/2024 12:49:06 | Chg.+0.65 | Bid22:00:29 | Ask22:00:29 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.19EUR | +25.59% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 230.00 USD | 20/06/2025 | Call |
Newsfile Corp
12/08
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
25/06
argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire
24/06
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
24/06
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
24/06
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
13/06
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
12/06
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
12/06
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...